Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Parkins

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Vaccine|March 15, 2012
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in miceRob Tierney, Toru Nakai, Christopher J Parkins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancerElena N Klyushnenkova, Diana V Kouiavskaia, Christopher J Parkins, et al.
Plos Neglected Tropical Diseases|August 23, 2011
A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virusYoshimi Tsuda, Patrizia Caposio, Christopher J Parkins, et al.
Antiviral Research|May 1, 2018
Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virionsJessica L Smith, Kayla Sheridan, Christopher J Parkins, et al.
Vaccine|March 31, 2015
A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single doseYoshimi Tsuda, Christopher J Parkins, Patrizia Caposio, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Viral and host network analysis of the human cytomegalovirus transcriptome in latencyDonna Collins-McMillen, Diogo De Oliveira Pessoa, Kristen Zarrella, et al.
Scientific Reports|February 16, 2016
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infectionAndrea Marzi, Aisling A Murphy, Friederike Feldmann, et al.
Frontiers in Aging Neuroscience|July 2, 2025
Effects of West Nile virus on behavioral and cognitive performance, cortical Aβ pathology, viral loads, and immune measures of middle-aged NL-G-F/E3 and NL-G-F/E4 miceAbigail O'Niel, Christopher J Parkins, Alexandra Pederson, et al.
Plos Pathogens|December 11, 2024
Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized miceNicole L Diggins, Andrew H Pham, Jennifer Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2025
Viral and host network analysis of the human cytomegalovirus transcriptome in latencyDonna Collins-McMillen, Diogo De Oliveira Pessoa, Kristen Zarrella, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|March 15, 2012
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in miceRob Tierney, Toru Nakai, Christopher J Parkins, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2012
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancerElena N Klyushnenkova, Diana V Kouiavskaia, Christopher J Parkins, et al.
Plos Neglected Tropical Diseases|August 23, 2011
A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virusYoshimi Tsuda, Patrizia Caposio, Christopher J Parkins, et al.
Antiviral Research|May 1, 2018
Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virionsJessica L Smith, Kayla Sheridan, Christopher J Parkins, et al.
Vaccine|March 31, 2015
A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single doseYoshimi Tsuda, Christopher J Parkins, Patrizia Caposio, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Viral and host network analysis of the human cytomegalovirus transcriptome in latencyDonna Collins-McMillen, Diogo De Oliveira Pessoa, Kristen Zarrella, et al.
Scientific Reports|February 16, 2016
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infectionAndrea Marzi, Aisling A Murphy, Friederike Feldmann, et al.
Frontiers in Aging Neuroscience|July 2, 2025
Effects of West Nile virus on behavioral and cognitive performance, cortical Aβ pathology, viral loads, and immune measures of middle-aged NL-G-F/E3 and NL-G-F/E4 miceAbigail O'Niel, Christopher J Parkins, Alexandra Pederson, et al.
Plos Pathogens|December 11, 2024
Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized miceNicole L Diggins, Andrew H Pham, Jennifer Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2025
Viral and host network analysis of the human cytomegalovirus transcriptome in latencyDonna Collins-McMillen, Diogo De Oliveira Pessoa, Kristen Zarrella, et al.
Pageof 3